Wanlong Ma
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 17
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Chronic Lymphocytic Leukemia Research 8
- Hematology 17
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 6
- Co-authors
- Maher X. Albitar (50 shared papers)Hagop M. Kantarjian (23 shared papers)Ola Landgren (2 shared papers)Richard B. Hayes (1 shared paper)Fatima Abbasi (1 shared paper)Paolo Ghia (1 shared paper)Gerald E. Marti (1 shared paper)Neil E. Caporaso (1 shared paper)
- Journals
- Blood (12 papers)Leukemia Research (4 papers)Journal of Cancer (3 papers)Molecular Cancer Therapeutics (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesChinaDenmark
In The Last Decade
Wanlong Ma
56 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 59
- Genetics 500
- Hematology 227
- Cancer Research 93
- Pathology and Forensic Medicine 80
- Oncology 84
Countries citing papers authored by Wanlong Ma
This map shows the geographic impact of Wanlong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanlong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanlong Ma more than expected).
Fields of papers citing papers by Wanlong Ma
This network shows the impact of papers produced by Wanlong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanlong Ma. The network helps show where Wanlong Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanlong Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 287 | |
| 2 | 2020 | 82 | |
| 3 | 2008 | 72 | |
| 4 | 2008 | 56 | |
| 5 | 2009 | 48 | |
| 6 | 2018 | 44 | |
| 7 | 2020 | 39 | |
| 8 | 2011 | 34 | |
| 9 | 2016 | 34 | |
| 10 | 2008 | 33 | |
| 11 | 2009 | 31 | |
| 12 | 2009 | 27 | |
| 13 | 2017 | 26 | |
| 14 | 2009 | 23 | |
| 15 | 2012 | 22 | |
| 16 | 2017 | 22 | |
| 17 | 2016 | 21 | |
| 18 | 2009 | 19 | |
| 19 | 2010 | 18 | |
| 20 | 2010 | 18 |
About Wanlong Ma
Wanlong Ma is a scholar working on Genetics, Hematology, Cancer Research, Hepatology and Pulmonary and Respiratory Medicine, having authored 58 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Cancer Genomics and Diagnostics (8 papers), Chronic Myeloid Leukemia Treatments (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Genetics (500 citations), Hematology (227 citations), Cancer Research (93 citations), Pathology and Forensic Medicine (80 citations) and Oncology (84 citations). Wanlong Ma has collaborated with scholars based in United States, China and Denmark. Frequent co-authors include Maher X. Albitar, Hagop M. Kantarjian, Ola Landgren, Richard B. Hayes, Fatima Abbasi, Paolo Ghia, Gerald E. Marti, Neil E. Caporaso, Francis Joseph Giles and Chen-Hsiung Yeh. Their work appears in journals such as Blood, Leukemia Research, Journal of Cancer, Molecular Cancer Therapeutics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.